Luzon, Sanny Boy C.
HRN: 26-93-38 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2025
CO-AMOXICLAV 625MG (TAB)
04/10/2025
04/24/2025
PO
625mg Tab
TID
Animal (cat) Bite, Category III
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes